Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-000585

Director gave up 4,315 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CANNON JAMES ANTHONY Director 2018-12-29 Shares withheld for taxes −4,315 $1.66 $7,163 383,050 D
Derivatives
CANNON JAMES ANTHONY Director 2018-12-31 Grant or award · Stock Option (right to buy) +126,700 126,700 D
Loading xslF345X03/doc4.xml…